Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kouzarides

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Nature Genetics|March 4, 2000
Mutations truncating the EP300 acetylase in human cancersS A Gayther, S J Batley, L Linger, et al.
Leukemia|August 10, 2013
BET protein inhibition shows efficacy against JAK2V617F-driven neoplasmsB S Wyspiańska, A J Bannister, I Barbieri, et al.
Leukemia|November 14, 2013
Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemiaM A Dawson, E J Gudgin, S J Horton, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Nature Genetics|March 4, 2000
Mutations truncating the EP300 acetylase in human cancersS A Gayther, S J Batley, L Linger, et al.
Leukemia|August 10, 2013
BET protein inhibition shows efficacy against JAK2V617F-driven neoplasmsB S Wyspiańska, A J Bannister, I Barbieri, et al.
Leukemia|November 14, 2013
Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemiaM A Dawson, E J Gudgin, S J Horton, et al.
Pageof 9